![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
Recent advances in gout drugs
Cheng Shi1, Ziting Zhou1, Xiaowei Chi1
1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, PR China.
European Journal of Medicinal Chemistry
|November 6, 2022
Summary
Gout, an inflammatory arthritis from urate crystals, currently lacks a cure. This review explores current gout treatment drugs, focusing on anti-inflammatory, urate-excreting, and urate-production-inhibiting medications.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Gout is the most common inflammatory arthritis, characterized by urate crystal deposition.
- It is an autoinflammatory disease with a high incidence and potential for severe complications.
- Currently, no definitive cure for gout exists worldwide.
Purpose of the Study:
- To provide a comprehensive overview of current gout treatment drug research.
- To highlight the understanding of gout as an autoinflammatory disease.
- To offer a basis for new gout drug discovery strategies.
Main Methods:
- Review of existing literature on gout treatment drugs.
- Categorization of drugs based on mechanism of action: anti-inflammatory, uricosuric, and uric acid production inhibitors.
- Emphasis on the autoinflammatory nature of gout and its implications for drug discovery.
Main Results:
- The review covers progress in anti-inflammatory and analgesic drugs for gout.
- It details advancements in drugs that promote uric acid excretion (uricosurics).
- It discusses emerging therapies that inhibit uric acid production.
Conclusions:
- Understanding gout as an autoinflammatory disease is crucial for developing novel therapeutics.
- Current research focuses on diverse drug classes to manage gout symptoms and underlying causes.
- This review provides a systematic basis for future gout drug discovery efforts.
Related Concept Videos
01:30Urinary Tract Calculi III: Medical Management
15
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
15
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
602
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
602
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
23
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
23
01:26Targets for Drug Action: Overview
7.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.2K
01:24Glucagon-like Receptor Agonists
386
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
386
01:29Drugs for Treatment of Ulcerative Colitis in IBD
223
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
223